Cantex Pharmaceuticals, Inc., 10% Owner at CHIMERIX INC (CMRX), sold 6,500,000 shares at $5.75 ($37.4M) on 2021-09-14, disclosed to the SEC on 2021-09-16.
Open-market sale of $37.4M CMRX by 10% Owner. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.